Skip to main content

Blog tinkering

As techno-challenged as I may be, I’ve been tinkering with my blog lately, and it’s been a blast. You’ll notice the new font. Most of my regular blog readers, I’m guessing, are visually impaired. While the old font looked great on my computer at home, I took a quick peek at the blog at work today and noticed the font was really hard to read on that screen. So, I’m hoping perhaps this will be a bit easier on the eyes.

Also, I installed a counter. Yep, can’t help it. I’m a journalist egomaniac and I’ve just got to know if anyone is actually reading this. I can’t imagine why they would, but still, my curiosity got the better of me.

And what do you know. Someone is actually reading it! So far 156 people since I installed the counter a week ago in fact. Most, however, are probably just blog hopping as they really don’t stay long enough to actually read much, but almost half make a return visit.

But, about 25 percent of readers spend 20 minutes to an hour – so either someone is reading or there are a lot of people getting up to get a snack and take a potty break when my blog appears on their screen. Considering the subject matter of this blog is only of interest to a limited number of people, my ego was sufficiently satisfied.


The other fun thing was to look at where visitors are coming from. Ninety-two percent are from the United States (no surprises there), but there have been a number of hits from Australia, Japan, Canada and Portugal. I have reason to believe there may be a higher than average number of people with Hermansky-Pudlak Syndrome in Japan and Portugal, so I’m really curious to know if that was by chance, or if they were intentionally looking for something Hermansky-Pudlak Syndrome related.

Comments

Anonymous said…
Hi Heather, I am reading.

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria